CAMBRIDGE EPIGENETIX

Cambridge Epigenetix aims to change the way medicine is practiced by reducing several routine and important diagnostic screening and detection tests for colorectal cancer and other common tumours to a simple blood draw. CEGX is pioneering the field of clinical epigenetics, and the company’s technology has proven the link between the epigenetic DNA modification 5-hydroxymethylcytosine (5hmC) and disease. Research has revealed a wide range of diagnostic and prognostic applications for 5hmC, no... w one of the most important biomarkers in the quest to improve human health. Spun-out of the University of Cambridge in 2012, CEGX was founded to develop and commercialise the science of world leading researchers Professor Sir Shankar Balasubramanian, co-inventor of Solexa sequencing, and Professor Anjana Rao, who identified the essential role of the TET enzymes and 5hmC in development and disease. A privately held company headquartered in Cambridge, UK, Cambridge Epigenetix is supported by several high-profile investors: GV (Google Ventures), Sequoia, Syncona, New Science Ventures, Ahren Innovation Capital, DNA Capital and the University of Cambridge.

#SimilarOrganizations #People #Financial #Event #Website #More

CAMBRIDGE EPIGENETIX

Social Links:

Twitter

Industry:

Biotechnology Health Care Health Diagnostics Medical

Founded:

2012-01-01

Address:

Cambridge, Cambridgeshire, United Kingdom

Country:

United Kingdom

Website Url:

http://www.cambridge-epigenetix.com

Total Employee:

51+

Status:

Active

Contact:

+44 1223 800700

Email Addresses:

[email protected]

Total Funding:

155.19 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome

Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

foundation-medicine-logo

Foundation Medicine

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.

metabolomic-diagnostics-logo

Metabolomic Diagnostics

Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases

knopp-biosciences-logo

Knopp Biosciences

Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.

redcliffe-labs-logo

Redcliffe Labs

Redcliffe is a one-stop diagnostic platform offering a wide selection of tests to choose from and delivering care closer to the customer.

xrapid-logo

xRapid

xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.

Current Advisors List

roelof-botha_image

Roelof Botha Board Observer @ Cambridge Epigenetix
Board_member
2015-12-01

bobby-yerramilli-rao_image

Bobby Yerramilli-Rao Member of the Board of Directors @ Cambridge Epigenetix
Board_member
2012-04-01

nick-mccooke_image

Nick McCooke Consultant Advisor @ Cambridge Epigenetix
Advisor
2012-04-01

not_available_image

Wolf Reik Scientific Advisor @ Cambridge Epigenetix
Advisor
2012-04-01

Current Employees Featured

shankar-balasubramian_image

Shankar Balasubramian
Shankar Balasubramian Co-Founder and Director @ Cambridge Epigenetix
Co-Founder and Director
2012-04-01

bobby-yerramilli-rao_image

Bobby Yerramilli-Rao
Bobby Yerramilli-Rao Co-Founder and Director @ Cambridge Epigenetix
Co-Founder and Director
2012-04-01

joanna-holbrook_image

Joanna Holbrook
Joanna Holbrook Senior Vice President of Research @ Cambridge Epigenetix
Senior Vice President of Research
2019-01-01

fiona-stewart_image

Fiona Stewart
Fiona Stewart Chief Financial Officer @ Cambridge Epigenetix
Chief Financial Officer
2020-10-01

gareth-ridge_image

Gareth Ridge
Gareth Ridge Senior Vice President of Operations & Site Head @ Cambridge Epigenetix
Senior Vice President of Operations & Site Head
2020-01-01

peter-fromen_image

Peter Fromen
Peter Fromen Chief Executive Officer @ Cambridge Epigenetix
Chief Executive Officer
2022-06-01

nathan-williams_image

Nathan Williams
Nathan Williams Facilities & IT Manager @ Cambridge Epigenetix
Facilities & IT Manager
2014-09-01

not_available_image

Martin Murphy
Martin Murphy Associate Director @ Cambridge Epigenetix
Associate Director
2012-04-01

Founder

bobby-yerramilli-rao_image

Bobby Yerramilli-Rao

shankar-balasubramian_image

Shankar Balasubramian

Investors List

new-science-ventures_image

Key Employee Changes

Date	New article
2022-06-14	Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer

Official Site Inspections

http://www.cambridge-epigenetix.com Semrush global rank: 5 M Semrush visits lastest month: 1.68 K

Host Informations
Whois Informations

Loading ...